Successful Treatment of Primary Cutaneous Anaplastic Large Cell Lymphoma with Denileukin Diftitox
Primary cutaneous anaplastic large cell lymphoma (PCALCL) is a rare variant of cutaneous T cell lymphoma (CTCL) characterized by CD30-expressing large atypical cells with kidney-shaped nuclei called hallmark cells. Since PCALCL is a rare variant of CTCL, the treatment of PCALCL is still controversia...
Main Authors: | Mayuko Amagai, Sadanori Furudate, Kentaro Ohuchi, Toshiya Takahashi, Emi Yamazaki, Hiromu Chiba, Yoshihide Asano, Taku Fujimura |
---|---|
Format: | Article |
Language: | English |
Published: |
Karger Publishers
2022-08-01
|
Series: | Case Reports in Oncology |
Subjects: | |
Online Access: | https://www.karger.com/Article/FullText/526312 |
Similar Items
-
Production of Recombinant Denileukin Diftitox: Assessment in the Lab-scale Bioreactor
by: Seyed Morteza Robatjazi, et al.
Published: (2019-08-01) -
Advanced-Stage Primary Cutaneous T-Cell Lymphoma Treated with Bexarotene and Denileukin Diftitox
by: Iván Cervigón-González, et al.
Published: (2011-02-01) -
Molecular Docking and In Silico Study of Denileukin Diftitox: Comparison of Wild Type With C519S Mutant
by: Mohamad Najarasl, et al.
Published: (2020-05-01) -
Targeting regulatory T cells by E7777 enhances CD8 T-cell–mediated anti-tumor activity and extends survival benefit of anti-PD-1 in solid tumor models
by: Haider S. Mahdi, et al.
Published: (2023-10-01) -
Profiles of Tumor-Infiltrating Lymphocytes in a Case of Trichilemmal Carcinoma with Spontaneous Regression
by: Sadanori Furudate, et al.
Published: (2012-10-01)